Back to Search
Start Over
Unrelated cord blood transplantation for adult patients with acute myeloid leukemia: higher incidence of acute graft-versus-host disease and lower survival in male patients transplanted with female unrelated cord blood--a report from Eurocord, the Acute Leukemia Working Party, and the Cord Blood Committee of the Cellular Therapy and Immunobiology Working Party of the European Group for Blood and Marrow Transplantation
- Source :
- Dipòsit Digital de Documents de la UAB, Universitat Autònoma de Barcelona, Journal of Hematology and Oncology, Journal of Hematology and Oncology, BioMed Central, 2015, 8 (1), pp.107. ⟨10.1186/s13045-015-0207-4⟩, Journal of Hematology and Oncology, 2015, 8 (1), pp.107. ⟨10.1186/s13045-015-0207-4⟩, Journal of Hematology & Oncology, r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau, instname, JOURNAL OF HEMATOLOGY & ONCOLOGY, r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
- Publication Year :
- 2015
-
Abstract
- Background In the setting of allogeneic human leukocyte antigen (HLA)-matched bone marrow transplantation, transplanting male patients with grafts from female donors has been associated with a higher incidence of graft-versus-host disease (GVHD) and of nonrelapse mortality (NRM). The aim of the current analysis was to compare transplantation outcomes in male patients given female unrelated cord blood (UCB) versus other gender combinations. Patients and methods Data from 552 consecutive patients with acute myeloid leukemia (AML) given a single UCB transplantation between 2000 and 2014 were included. Results In comparison with other gender combination, male patients given female UCB (n = 131) had a trend for a higher incidence of grades II–IV acute GVHD (33 versus 25 %, P = 0.08), a trend for a higher incidence of NRM (41 versus 33 %, P = 0.06), and a lower leukemia-free (LFS, 30 versus 41 %, P = 0.01) and overall survival (OS, 33 versus 45 %, P = 0.008). In multivariate analyses, taking into consideration all patients for which data on HLA-matching and cell dose transplanted were fully available (n = 363), male patients transplanted with a female UCB had a trend for a higher incidence of grade III–IV acute GVHD (hazard ratio (HR) = 2.0, P = 0.06), a trend for a higher NRM (HR = 1.5, P = 0.06), and a worse LFS (HR = 1.4, P = 0.04) and OS (HR = 1.3, P = 0.06). Conclusions Our data suggest that male patients transplanted with female UCB might have higher risk of acute GVHD and of NRM leading to worse LFS and OS. These results should be confirmed in other large cohorts of patients before used for determining the choice of an UCB unit. Electronic supplementary material The online version of this article (doi:10.1186/s13045-015-0207-4) contains supplementary material, which is available to authorized users.
- Subjects :
- Male
Cancer Research
[SDV]Life Sciences [q-bio]
GVHD
Graft vs Host Disease
Blood Donors
0302 clinical medicine
AML
Risk Factors
hemic and lymphatic diseases
Medicine
0303 health sciences
Acute leukemia
Hematology
Incidence
Hazard ratio
Middle Aged
3. Good health
Europe
Survival Rate
[SDV] Life Sciences [q-bio]
Leukemia
surgical procedures, operative
Oncology
Leukemia, Myeloid
030220 oncology & carcinogenesis
Cord blood
Acute Disease
Female
Cord Blood Stem Cell Transplantation
Adult
medicine.medical_specialty
Adolescent
03 medical and health sciences
Young Adult
Sex Factors
Unrelated cord blood
Sang fetal
Internal medicine
Humans
Survival rate
Molecular Biology
030304 developmental biology
Aged
Retrospective Studies
Transplantation
business.industry
Research
medicine.disease
Survival Analysis
Surgery
Multivariate Analysis
business
Subjects
Details
- ISSN :
- 17568722
- Database :
- OpenAIRE
- Journal :
- Dipòsit Digital de Documents de la UAB, Universitat Autònoma de Barcelona, Journal of Hematology and Oncology, Journal of Hematology and Oncology, BioMed Central, 2015, 8 (1), pp.107. ⟨10.1186/s13045-015-0207-4⟩, Journal of Hematology and Oncology, 2015, 8 (1), pp.107. ⟨10.1186/s13045-015-0207-4⟩, Journal of Hematology & Oncology, r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau, instname, JOURNAL OF HEMATOLOGY & ONCOLOGY, r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
- Accession number :
- edsair.doi.dedup.....894f23680e04c8a0525d1b3c6caa82f3